Colorectal cancer and blood sugar study
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at how blood sugar levels and family history may be connected to colorectal cancer. By joining, you help researchers learn more about possible shared causes, which might lead to better prevention or treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 85 years old.
- You have been recently diagnosed with colorectal cancer (a type of cancer starting in the colon or rectum).
- You have never been told by a doctor that you have diabetes (a condition where blood sugar is too high).
- You do not have severe obesity, which this study defines as a body mass index (BMI) of 35 or higher.
- You are able to give written permission to be in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at metabolic biomarkers in blood and tumor tissue to help detect colorectal cancer earlier, predict outcomes, and monitor for recurrence. It includes both people newly diagnosed with colorectal cancer and healthy volunteers for comparison.
This study is collecting blood samples to improve a test that looks for signs of colorectal cancer in the blood. It may help find cancer earlier or better understand how to detect it.
This study is looking at whether adding a blood test can make the current stool-based screening for colorectal cancer more accurate. It may help find cancers earlier or reduce the need for colonoscopy.
This research study uses a blood test to look for signs of colorectal cancer in people who have other types of cancer or digestive diseases. The goal is to see if the test can correctly tell the difference between colorectal cancer and other conditions.
This study is collecting information from people with newly diagnosed colon or rectal cancer, to better understand the disease and support future research. It may help you and others by improving how colorectal cancer is studied and potentially treated over time.
This study looks at whether a simple blood test can help guide the care of people being evaluated for colorectal cancer. It may support earlier or clearer decision-making alongside existing screening or colonoscopy results.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.